Dr. Michael Duncan

Chad Newton is a Pulmonary Medicine provider in Dallas, Texas. Dr. Newton is rated as an Elite provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. His top areas of expertise are Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Mathai cares for patients with advanced lung and respiratory diseases. Her focus is on clinical care and research related to interstitial lung diseases and pulmonary fibrosis. Prior to joining the medical staff at Baylor University Medical Center in Dallas, she was a member of the faculty at the University of Colorado in Denver. She has published numerous peer-reviewed articles and is involved in research related to pulmonary fibrosis. She has received support for her work from the National Institutes of Health, the Parker B. Francis Foundation and the U.S. Department of Defense and currently serves as the principal investigator on numerous clinical trials related to treatments for interstitial lung diseases. She is active in medical education and directs the Pulmonary and Critical Care Medicine Fellowship at Baylor University Medical Center. Dr. Mathai is rated as a Distinguished provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant.

Yolanda Mageto, MD, MPH, a pulmonary critical care specialist with nationally recognized expertise in interstitial lung disease (ILD), has assumed the role of Medical Director of Interstitial Lung Disease at Baylor University Medical Center at Dallas. Dr. Mageto attended medical school at Washington University in St. Louis, Missouri and completed her residency and training at University of Texas Southwestern and her fellowship in pulmonary and critical care medicine at the University of Washington in Seattle with a focus in ILD. Since that time she has held faculty positions at the University of Washington Seattle, University of Texas Southwestern and most recently University of Vermont where she rose to the rank of full Professor. Dr. Mageto is a clinician, educator and researcher involved in multiple idiopathic pulmonary fibrosis/ILD trials over last 20 years including collaborations with investigators from other centers in sarcoidosis related lung disease. She remains actively involved in the total care and management of her patients. Dr. Mageto is dedicated to the development of a Comprehensive Integrated Interstitial Lung disease program optimizing delivery of care to patients with interstitial lung disease in the Dallas Fort Worth Area. In her spare time she enjoys spending time with her family, travelling, reading a good book and cooking. Dr. Mageto is rated as a Distinguished provider by MediFind in the treatment of Idiopathic Pulmonary Fibrosis. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Hypersensitivity Pneumonitis.